Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 253

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 253
---
 damages liabilities, as well as associated costs, diversion of internal resources and reputational harm. Any future acquisitions, in-licensingor strategic partnerships may increase Kineta’s capital requirements, dilute Kineta’s stockholders, divert Kineta’s management’s attention, cause Kineta to incur debt or assume contingent liabilities and subject Kineta to other risks. Kineta may engage in various acquisitions and strategic partnerships in the future, including licensing or acquiring complementary products, intellectual property rights, technologies or businesses. Any acquisition or strategic partnership may entail numerous risks, including:

| • |     | increased operating expenses and cash requirements; |

| • |     | the assumption of indebtedness or contingent liabilities; |

| • |     | the issuance of Kineta’s equity securities which would result in dilution to Kineta’s stockholders; |

| • |     | assimilation of operations, intellectual property, products and product candidates of an acquired company, including difficulties associated with integrating new personnel; |

| • |     | the diversion of Kineta’s management’s attention from Kineta’s existing product candidates and initiatives in pursuing such an acquisition or strategic partnership; |

| • |     | spend substantial operational, financial and management resources in integrating new businesses, technologies and products; |

| • |     | retention of key employees, the loss of key personnel and uncertainties in Kineta’s ability to maintain key business relationships; |

| • |     | risks and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing products or product candidates and regulatory approvals; and |

| • |     | Kineta’s inability to generate revenue from acquired intellectual property, technology and/or products sufficient to meet Kineta’s objectives or even to offset the associated transaction and maintenance costs. |

**In addition, if Kineta undertakes such a transaction, Kineta may incur large one-timeexpenses and acquire intangible assets that could result in significant future amortization expense. 149

Risks Relating to Kineta’s Intellectual Property

If Kineta is unable to obtain and maintain sufficient intellectual property protection for its platform technologies and product candidates, or if the scope of the intellectual property protection is not sufficiently broad, Kineta’s competitors could develop and commercialize products similar or identical to Kineta’s, and Kineta’s ability to successfully commercialize its products may be adversely affected.

Kineta relies upon a combination of patents, know-how and confidentiality agreements to protect the intellectual property related to Kineta’s products and technologies and to prevent third parties from